Please ensure Javascript is enabled for purposes of website accessibility

CardioNet Trims Loss in Q1

By Eric Volkman - Apr 22, 2013 at 9:55PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is still in the red, but it's managed to reduce its quarterly shortfall.

CardioNet's (BEAT) results for the fiscal Q1 2013 have been released. For the quarter, top line came in at $32.4 million, a nearly 20% increase from the $27.0 million recorded in the same period the previous year. Net loss narrowed over that time span, to $2.1 million ($0.08 per diluted share) from Q1 2012's red figure of $3.5 million ($0.14).

CardioNet attributed the higher revenue figure to growth in its take for research services, which improved by $5.4 million on a year-over-year basis. This was due in large part to its acquisition of research entity Cardiocore last summer. Additionally, patient services revenue was $1.0 million higher in the most recent quarter.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

BioTelemetry, Inc. Stock Quote
BioTelemetry, Inc.
BEAT

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/23/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.